Long-term follow-up helicobacter pylori reinfection rate and its associated factors in Korea

Helicobacter

Volumn 18, Issue 2, 2013, Pages 135-142

  Kim, Min Soo ^a   Kim, Nayoung ^a,b   Kim, Sung Eun ^a   Jo, Hyun Jin ^a   Shin, Cheol Min ^a   Lee, Sang Hyub ^a   Park, Young Soo ^a,b   Hwang, Jin Hyeok ^a,b   Kim, Jin Wook ^a,b   Jeong, Sook Hyang ^a,b   Lee, Dong Ho ^a,b   Kim, Jung Mogg ^c   Jung, Hyun Chae ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Associated factors; Helicobacter pylori; Reinfection

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN;

ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENDER; GIEMSA STAIN; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INCOME; INTESTINE METAPLASIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REINFECTION; RISK FACTOR; SMOKING; SOCIAL STATUS; STOMACH MUCOSA; UREA BREATH TEST;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BREATH TESTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RECURRENCE; REPUBLIC OF KOREA; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84875037308     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12018     Document Type: Article

References (48)

1. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-8.
2. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.
4. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
5. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2.
6. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
7. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23:351-65.
8. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 2012;61:646-64.
9. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25.
10. Kim JM, Kim JS, Jung HC, et al. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother 2004;48:4843-7.
11. Kim N, Kim JM, Kim CH, et al. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. J Clin Gastroenterol 2006;40:683-7.
12. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005;100:2083-99.
13. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-40.
14. Kim N, Lim SH, Lee KH, et al. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 1998;27:321-6.
15. Cheon JH, Kim N, Lee DH, et al. Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea. Eur J Gastroenterol Hepatol 2006;18:515-9.
16. Na HS, Hong SJ, Yoon HJ, et al. Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication. Korean J Gastroenterol 2007;50:170-5.
17. Lee JH, Kim N, Chung JI, et al. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter 2008;13:288-94.
18. Zhang YY, Xia HH, Zhuang ZH, et al. Review article: 'true' re-infection of Helicobacter pylori after successful eradication-worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther 2009;29:145-60.
19. Noh YW, Jung HK, Kim SE, et al. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil 2010;16:148-56.
20. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
21. Cameron EA, Bell GD, Baldwin L, et al. Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2006;23:1355-8.
22. Peitz U, Hackelsberger A, Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 1999;57:905-20.
23. Bell GD, Powell KU. Helicobacter pylori reinfection after apparent eradication-the Ipswich experience. Scand J Gastroenterol Suppl 1996;215:96-104.
24. Hildebrand P, Bardhan P, Rossi L, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001;121:792-8.
25. Soto G, Bautista CT, Roth DE, et al. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003;188:1263-75.
26. Rothenbacher D, Inceoglu J, Bode G, et al. Acquisition of Helicobacter pylori infection in a high-risk population occurs within the first 2 years of life. J Pediatr 2000;136:744-8.
27. Miyaji H, Azuma T, Ito S, et al. Helicobacter pylori infection occurs via close contact with infected individuals in early childhood. J Gastroenterol Hepatol 2000;15:257-62.
28. Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359:931-5.
29. Rothenbacher D, Bode G, Berg G, et al. Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission. J Infect Dis 1999;179:398-402.
30. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9(Suppl 2):45-51.
31. Kim N, Lim SH, Lee KH, et al. Seroconversion of Helicobacter pylori in Korean male employees. Scand J Gastroenterol 2005;40:1021-7.
32. Gomez Rodriguez BJ, Rojas Feria M, Garcia Montes MJ, et al. Incidence and factors influencing on Helicobacter pylori infection recurrence. Rev Esp Enferm Dig 2004;96:620-3.
33. Shimizu T, Yarita Y, Kaneko K, et al. Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy. Pediatr Infect Dis J 2000;19:901-3.
34. Gisbert JP, Arata IG, Boixeda D, et al. Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002;14:865-71.
35. Karczewska E, Konturek JE, Konturek PC, et al. Oral cavity as a potential source of gastric reinfection by Helicobacter pylori. Dig Dis Sci 2002;47:978-86.
36. Kilmartin CM. Dental implications of Helicobacter pylori. J Can Dent Assoc 2002;68:489-93.
37. Sugiyama T, Naka H, Yachi A, et al. Direct evidence by DNA fingerprinting that endoscopic cross-infection of Helicobacter pylori is a cause of postendoscopic acute gastritis. J Clin Microbiol 2000;38:2381-2.
38. McMahon BJ, Bruce MG, Hennessy TW, et al. Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment Pharmacol Ther 2006;23:1215-23.
39. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002;14:1119-23.
40. Leal-Herrera Y, Torres J, Monath TP, et al. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol 2003;98:2395-402.
41. Thong-Ngam D, Mahachai V, Kullavanijaya P. Incidence of Helicobacter pylori recurrent infection and associated factors in Thailand. J Med Assoc Thai 2007;90:1406-10.
42. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000;181:1359-63.
43. Woodward M, Morrison C, McColl K. An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 2000;53:175-81.
44. Moayyedi P, Axon AT, Feltbower R, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002;31:624-31.
45. Bures J, Kopacova M, Koupil I, et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006;11:56-65.
46. Celinski K, Kurzeja-Miroslaw A, Slomka M, et al. The effects of environmental factors on the prevalence of Helicobacter pylori infection in inhabitants of Lublin Province. Ann Agric Environ Med 2006;13:185-91.
47. Aydin A, Ersoz G, Ozutemiz O, et al. Low reinfection rate of Helicobacter pylori infection in Turkey. J Clin Gastroenterol 2000;30:337.
48. Shi R, Xu S, Zhang H, et al. Prevalence and risk factors for Helicobacter pylori infection in Chinese populations. Helicobacter 2008;13:157-65.